Clinical Trial Update: Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy, safety and tolerability of macitentan in inoperable chronic thromboembolic pulmonary hypertension has completed; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Macitentan (macitentan)

Snippet

Sponsor: Actelion | Conditions: Chronic Thromboembolic Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2018-01-23